Ameritas Investment Partners’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-3,224
| Closed | -$109K | – | 3050 |
|
|
2022
Q4 | $109K | Hold |
3,224
| – | – | ﹤0.01% | 1529 |
|
|
2022
Q3 | $101K | Hold |
3,224
| – | – | ﹤0.01% | 1486 |
|
|
2022
Q2 | $98K | Sell |
3,224
-332
| -9% | -$8.98K | ﹤0.01% | 1528 |
|
|
2022
Q1 | $92K | Hold |
3,556
| – | – | ﹤0.01% | 1713 |
|
|
2021
Q4 | $73K | Hold |
3,556
| – | – | ﹤0.01% | 1887 |
|
|
2021
Q3 | $68K | Hold |
3,556
| – | – | ﹤0.01% | 1955 |
|
|
2021
Q2 | $79K | Hold |
3,556
| – | – | ﹤0.01% | 1880 |
|
|
2021
Q1 | $93K | Hold |
3,556
| – | – | ﹤0.01% | 1723 |
|
|
2020
Q4 | $66K | Hold |
3,556
| – | – | ﹤0.01% | 1825 |
|
|
2020
Q3 | $60K | Hold |
3,556
| – | – | ﹤0.01% | 1730 |
|
|
2020
Q2 | $83K | Hold |
3,556
| – | – | ﹤0.01% | 1532 |
|
|
2020
Q1 | $30K | Hold |
3,556
| – | – | ﹤0.01% | 1960 |
|
|
2019
Q4 | $35K | Hold |
3,556
| – | – | ﹤0.01% | 2120 |
|
|
2019
Q3 | $34K | Hold |
3,556
| – | – | ﹤0.01% | 2111 |
|
|
2019
Q2 | $42K | Hold |
3,556
| – | – | ﹤0.01% | 2015 |
|
|
2019
Q1 | $63K | Hold |
3,556
| – | – | ﹤0.01% | 1748 |
|
|
2018
Q4 | $62K | Hold |
3,556
| – | – | ﹤0.01% | 1687 |
|
|
2018
Q3 | $53K | Hold |
3,556
| – | – | ﹤0.01% | 1966 |
|
|
2018
Q2 | $57K | Hold |
3,556
| – | – | ﹤0.01% | 1901 |
|
|
2018
Q1 | $50K | Hold |
3,556
| – | – | ﹤0.01% | 1934 |
|
|
2017
Q4 | $50K | Hold |
3,556
| – | – | ﹤0.01% | 1932 |
|
|
2017
Q3 | $49K | Hold |
3,556
| – | – | ﹤0.01% | 1913 |
|
|
2017
Q2 | $56K | Hold |
3,556
| – | – | ﹤0.01% | 1840 |
|
|
2017
Q1 | $49K | Buy |
+3,556
| New | +$49.7K | ﹤0.01% | 1867 |
|
|
2014
Q4 | – | Sell |
-41,500
| Closed | -$734K | – | 1203 |
|
|
2014
Q3 | $734K | Hold |
41,500
| – | – | 0.05% | 393 |
|
|
2014
Q2 | $856K | Buy |
+41,500
| New | +$853K | 0.06% | 340 |
|
Other funds holding VIVO
Ameritas Investment Partners's VIVO Position: Q1 2023 in Review
Ameritas Investment Partners sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 3,224 shares — an estimated $109K sold.
Ameritas Investment Partners first reported a position in VIVO in Q2 2014 and held it in 26 quarters. The position peaked at $856K in Q2 2014. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.
- Ameritas Investment Partners reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
- Ameritas Investment Partners sold 3,224 Meridian Bioscience Inc shares in Q1 2023, an estimated $109K.
- Ameritas Investment Partners first reported a position in Meridian Bioscience Inc in Q2 2014 and held it in 26 quarters.
- Ameritas Investment Partners's Meridian Bioscience Inc position peaked at $856K in Q2 2014.
- 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.
Based on Ameritas Investment Partners's 13F filing for Q1 2023, filed 10 May 2023.